Paid Clinical Trials in Tennessee

Tennessee has 2,156 paid clinical trials enrolling now across cities including Nashville, Memphis and Knoxville. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Tennessee include Vanderbilt University Medical Center and St. Jude Children's Research Hospital, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

2,156 clinical trials

↓ Download CSV

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

for Lymphoma, Non-Hodgkin

23 locations incl. Duarte

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07101328·Phase 1·Not Yet Recruiting

Stakeholders of Rare Diseases Informing Values In Neuroethics

for Rare Disorder

1 location in Memphis

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: All ages

Code: NCT07314736·Recruiting

Apply to this trial

Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma

for Pediatric Osteosarcoma

1 location in Memphis

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: Up to 21

Code: NCT07428993·Phase 2·Recruiting

Apply to this trial

A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

for Obesity

17 locations incl. Cullman

Sponsor: Verdiva Bio Dev Limited

Sex: All·Age: 18 - 80

Code: NCT07553299·Phase 2·Not Yet Recruiting

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for Pancreatic Cancer

Drug: Atebimetinib

12 locations incl. Phoenix

Sponsor: Immuneering Corporation

Sex: All·Age: 18+

Code: NCT07562152·Phase 3·Recruiting

Apply to this trial

Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders

for Bone Marrow Failure Syndrome

1 location in Memphis

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: 18 - 25

Code: NCT07585136·Phase 1·Not Yet Recruiting

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

for Overweight

Drug: Eloralintide

40 locations incl. The Villages

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 75

Code: NCT07589608·Phase 2·Not Yet Recruiting

Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE

for Atherosclerotic Cardiovascular Disease

1 location in Memphis

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: 18+

Code: NCT07594392·Not Yet Recruiting

A Study in Adults With Geographic Atrophy

for Geographic Atrophy

20 locations incl. Bakersfield

Sponsor: Sitala Bio LTD

Sex: All·Age: 60+

Code: NCT07606365·Phase 2·Not Yet Recruiting

A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM

for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

24 locations incl. La Jolla

Sponsor: AstraZeneca

Sex: All·Age: 18 - 85

Code: NCT07608354·Phase 2·Not Yet Recruiting

A Study of CS231295 in Patients With Advanced Solid Tumors

for Advance Solid Tumors

4 locations incl. Denver

Sponsor: ThalassaX Therapeutics United States Ltd

Sex: All·Age: 18+

Code: NCT07612488·Phase 1·Not Yet Recruiting

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

for Major Depressive Episode (MDE)

25 locations incl. Phoenix

Sponsor: Tonix Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07621237·Phase 2·Recruiting

Apply to this trial

DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.

for Obstructive Sleep Apnea (OSA)

14 locations incl. Chula Vista

Sponsor: Incannex Healthcare Ltd

Sex: All·Age: 18 - 65

Code: NCT07635563·Phase 2·Not Yet Recruiting

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

for Systemic Sclerosis

Drug: Nerandomilast

30 locations incl. Birmingham

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07497087·Phase 3·Not Yet Recruiting

DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

for Extrapulmonary Neuroendocrine Cancer

Drug: Obrixtamig

21 locations incl. Scottsdale

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07544654·Phase 3·Not Yet Recruiting

Beginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AG

for Alpha-Gal Syndrome

4 locations incl. Little Rock

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All·Age: 12 - 50

Code: NCT07611435·Phase 2·Not Yet Recruiting

Exogenous Ketone Supplementation in ICU Delirium

for ICU Delirium

1 location in Nashville

Sponsor: Vanderbilt University Medical Center

Sex: All·Age: 18+

Code: NCT07364162·Phase 1·Recruiting

Apply to this trial

A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity

for Obesity

Drug: NNC0662-0419

24 locations incl. Montgomery

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07639021·Phase 2·Not Yet Recruiting

Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma

for Hodgkin Lymphoma

1 location in Memphis

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: 10 - 25

Code: NCT07222345·Recruiting

Apply to this trial

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

for Advanced Clear Cell Renal Cell Carcinoma

41 locations incl. Fayetteville

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT07383441·Phase 3·Recruiting

Apply to this trial

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

for Relapsed Pediatric ALL

1 location in Memphis

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: Up to 21

Code: NCT07257419·Phase 1·Recruiting

Apply to this trial

Functional Ovarian Reserve in Sickle Cell Disease

for Sickle Cell Disease

1 location in Memphis

Sponsor: St. Jude Children's Research Hospital

Sex: Female·Age: 10 - 18·Accepts healthy volunteers

Code: NCT07392216·Recruiting

Apply to this trial

A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control

for Myopia

12 locations incl. Birmingham

Sponsor: Jaeb Center for Health Research

Sex: All·Age: 5 - 11

Code: NCT07095894·Phase 3·Recruiting

Apply to this trial

PREcision MEDicine In Achalasia (PREMEDIA) - Cohort

for Type III Achalasia

13 locations incl. Scottsdale

Sponsor: Northwestern University

Sex: All·Age: 18+

Code: NCT07293689·Recruiting

Apply to this trial

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

for Chin Augmentation

8 locations incl. Westport

Sponsor: Galderma R&D

Sex: All·Age: 22+·Accepts healthy volunteers

Code: NCT07566286·Not Yet Recruiting

Valproic AcId for Traumatic BRAin INjury Trial

for Moderate Traumatic Brain Injury (TBI)

8 locations incl. Birmingham

Sponsor: Northwestern University

Sex: All·Age: 18 - 65

Code: NCT07166393·Phase 2, Phase 3·Not Yet Recruiting

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

for Breast Neoplasms

25 locations incl. Birmingham

Sponsor: Eli Lilly and Company

Sex: Female·Age: 18+

Code: NCT07287098·Phase 2·Not Yet Recruiting

A Study of CSTI-500 in Patients With Prader-Willi Syndrome

for Prader-Willi Syndrome

1 location in Nashville

Sponsor: ConSynance Therapeutics

Sex: All·Age: 13 - 50

Code: NCT07348601·Phase 2·Recruiting

Apply to this trial

Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)

for Atherosclerotic Cardiovascular Disease (ASCVD)

6 locations incl. Los Angeles

Sponsor: Stanford University

Sex: All·Age: 18 - 74

Code: NCT07355894·Not Yet Recruiting

PC400 Coils for Treatment of Intracranial Aneurysms

for Intracranial Aneurysms

1 location in Memphis

Sponsor: Semmes-Murphey Foundation

Sex: All·Age: 18 - 80

Code: NCT07464847·Not Yet Recruiting

Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing

for Multiple Myeloma

Drug: Daratumumab

1 location in Nashville

Sponsor: Eden Biltibo

Sex: All·Age: 18 - 70

Code: NCT07485647·Phase 2·Not Yet Recruiting

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

for Small Cell Lung Cancer (SCLC )

3 locations incl. Hackensack

Sponsor: Moonlight Bio, Inc

Sex: All·Age: 18+

Code: NCT07488923·Phase 1·Not Yet Recruiting

Feasibility of Incorporating a Standardized Substance Use Measure With Linked-Brief Intervention Into Routine Psychosocial Care of Adult Childhood Cancer Survivors

for Survivors of Childhood Cancer

1 location in Memphis

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: 18+

Code: NCT07516301·Not Yet Recruiting

Muscle Aging Phenotypes in Childhood Cancer Survivors

for Muscle Weakness

1 location in Memphis

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07531498·Not Yet Recruiting

ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

for Coronary Artery Disease

16 locations incl. Phoenix

Sponsor: Emory University

Sex: All·Age: 18+

Code: NCT07559903·Not Yet Recruiting

Collection of Training Data for LuminX Probe AI Models

for Data Collection for AI Training of Dental Prob

3 locations incl. Beverly Hills

Sponsor: LuminX

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07565480·Not Yet Recruiting

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

for Obesity

11 locations incl. Walnut Creek

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07607587·Phase 1·Not Yet Recruiting

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

for Pneumococcal Disease

58 locations incl. Birmingham

Sponsor: Pfizer

Sex: All·Age: 42 Days - 211 Days·Accepts healthy volunteers

Code: NCT07629440·Phase 3·Recruiting

Apply to this trial

A Phase 1 Study of the Safety and Tolerability of CTX-10726

for Gastroesophageal Cancer (GC)

Drug: CTX-10726

5 locations incl. Boston

Sponsor: Compass Therapeutics

Sex: All·Age: 18+

Code: NCT07419841·Phase 1·Recruiting

Apply to this trial

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

for Obesity

Drug: Semaglutide

99 locations incl. Birmingham

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07564414·Phase 3·Recruiting

Apply to this trial